PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jexpmedHomeThe Rockefeller University PressThis articleEditorsContactInstructions for AuthorsThis issue
 
J Exp Med. Jan 5, 2004; 199(1): 99–112.
PMCID: PMC1887720
Fyn and PTP-PEST–mediated Regulation of Wiskott-Aldrich Syndrome Protein (WASp) Tyrosine Phosphorylation Is Required for Coupling T Cell Antigen Receptor Engagement to WASp Effector Function and T Cell Activation
Karen Badour,ab Jinyi Zhang,ab Fabio Shi,ab Yan Leng,ab Michael Collins,ab and Katherine A. Siminovitchab
aDepartment of Medicine, Department of Immunology, Department of Medical Genetics and Microbiology, and Institute of Medical Science, University of Toronto, Toronto, ON M5G 1X5, Canada
bSamuel Lunenfeld and Toronto General Research Institutes, Mount Sinai Hospital and the University Health Network, Toronto, ON M5G 1X5, Canada
Address correspondence to Katherine A. Siminovitch, Mount Sinai Hospital, 600 University Avenue, Room 656A, Toronto, ON M5G 1X5, Canada. Phone: (416) 586-8723; Fax: (416) 586-8731; email: ksimin/at/mshri.on.ca
Received June 13, 2003; Accepted October 22, 2003.
Involvement of the Wiskott-Aldrich syndrome protein (WASp) in promoting cell activation requires its release from autoinhibitory structural constraints and has been attributed to WASp association with activated cdc42. Here, however, we show that T cell development and T cell receptor (TCR)-induced proliferation and actin polymerization proceed normally in WASp−/− mice expressing a WASp transgene lacking the cdc42 binding domain. By contrast, mutation of tyrosine residue Y291, identified here as the major site of TCR-induced WASp tyrosine phosphorylation, abrogated induction of WASp tyrosine phosphorylation and its effector activities, including nuclear factor of activated T cell transcriptional activity, actin polymerization, and immunological synapse formation. TCR-induced WASp tyrosine phosphorylation was also disrupted in T cells lacking Fyn, a kinase shown here to bind, colocalize with, and phosphorylate WASp. By contrast, WASp was tyrosine dephosphorylated by protein tyrosine phosphatase (PTP)-PEST, a tyrosine phosphatase shown here to interact with WASp via proline, serine, threonine phosphatase interacting protein (PSTPIP)1 binding. Although Fyn enhanced WASp-mediated Arp2/3 activation and was required for synapse formation, PTP-PEST combined with PSTPIP1 inhibited WASp-driven actin polymerization and synapse formation. These observations identify key roles for Fyn and PTP-PEST in regulating WASp and imply that inducible WASp tyrosine phosphorylation can occur independently of cdc42 binding, but unlike the cdc42 interaction, is absolutely required for WASp contributions to T cell activation.
Keywords: WASp, lymphocyte activation, tyrosine phosphorylation, actin cytoskeletal arrangement
The Wiskott-Aldrich syndrome protein (WASp) is a hemopoietic lineage-restricted cytosolic effector of T cell activation, integrally involved in the coupling of TCR engagement to transcriptional activation and cytoskeletal rearrangement (1). WASp effects on TCR signaling are mediated through its tandemly located GTPase binding domain (GBD) and proline-rich region, flanking NH2-terminal–located Ena/Vasp homology 1, and COOH-terminal verprolin homology central region-acidic region (VCA) domains. The VCA domain represents a newly identified structural motif that provides WASp and several WASp-related proteins with the capacity to bind components of the Arp2/3 complex and thereby induce Arp2/3 actin-nucleating activity (2,3). Affinity of this domain for Arp2/3 complex binding has very recently been shown to be enhanced by its constitutive serine phosphorylation (4). The other functional domains of WASp complement this activity by mediating effector interactions that enable WASp recruitment into TCR signaling pathways and the consequent linkage of TCR stimulatory signals to induction of actin polymerization. For example, TCR-stimulated binding of the WASp proline-rich region to the SH3 domain–containing proline, serine, threonine phosphatase interacting protein (PSTPIP)1 adaptor, allows WASp to be targeted to the T cell–APC interface and thereby direct the regional actin cytoskeletal rearrangements required for formation of the immunological synapse (5). Similarly, WASp proline-rich region-mediated interactions with other SH3 domain–containing adaptors, such as CrkL and intersectin 2, and WASp Ena/Vasp homology 1 domain–mediated interactions with the WASp-interacting protein, WIP, appear to enable WASp translocation to specific subcellular sites wherein its actin polymerizing properties can be deployed so as to augment cell activation (69). Such interactions may also account for the capacity of WASp to modulate lipid raft clustering after TCR engagement (10). By contrast, the WASp GBD mediates an interaction with the activated form of the cdc42 Rho GTPase that does not modulate WASp localization, but instead induces WASp actin polymerizing function by releasing WASp from an autoinhibitory structural configuration that constrains VCA effects on the Arp2/3 complex (11).
The structural and biochemical data showing WASp actin polymerizing properties to be constitutively, but reversibly, autoinhibited, provide a mechanical explanation for the inducibility of actin cytoskeletal change in response to cell stimulation (12, 13). However, data showing that WASp promotes clustering in the absence of cdc42 binding imply that WASp Arp2/3 stimulatory function can be evoked by mechanisms other than cdc42-GTP association with its GBD (13). This possibility is also suggested by nuclear magnetic resonance data showing that a WASp tyrosine residue (Y291) in close proximity to the WASp GBD is structurally positioned such that its phosphorylation might disrupt WASp autoinhibitory conformation and thereby evoke VCA domain activity (12). This tyrosine residue has been shown to be phosphorylated in vitro by the protein tyrosine kinases (PTKs) Btk and Hck (14, 15), and its phosphorylation has been associated with enhanced macrophage filopodium formation (15). However, although WASp has also been shown to interact with Fyn and Itk (16, 17), the regulation of its tyrosine phosphorylation and the relevance of WASp tyrosine phosphorylation to its biological functions in T cells remain unknown.
In this study, the sites, mechanisms, and biologic relevance of WASp tyrosine phosphorylation in relation to T cell activation were investigated. The data indicate inducible phosphorylation of the WASp tyrosine residue at position 291 to be essential for the coupling of TCR engagement to NFAT activation, actin polymerization, and immunological synapse formation. By contrast, WASp effects on T cell development and activation as well as its inducible tyrosine phosphorylation can occur independently of the WASp GBD motif. The data also identify Fyn as the WASp-binding PTK required for phosphorylation of Y291 after TCR stimulation and indicate that WASp association with the PSTPIP1 adaptor allows WASp to colocalize with and be dephosphorylated by the protein tyrosine phosphatase (PTP), PTP-PEST. Like WASp, both Fyn and PTP-PEST are inducibly translocated to the contact zone formed between T cells and stimulatory APCs, but although WASp and Fyn are required for immunological synapse formation, PTP-PEST overexpression essentially abrogates synapse development. Similarly, Fyn markedly enhances, whereas PTP-PEST in combination with PSTPIP1 impairs, WASp capacity to stimulate Arp2/3 actin polymerizing activity in vitro. Importantly, Fyn effects on WASp phosphorylation and its actin polymerizing role appear to be unaffected by changes in cdc42 activity and disruption of the WASp–cdc42 interaction, respectively. These findings indicate Y291 phosphorylation to be essential to the triggering of WASp effector function during T cell activation. The data also reveal that WASp tyrosine phosphorylation can occur independently of WASp–cdc42 interaction and its modulation represents a key mechanism whereby Fyn and PTP-PEST regulate the signaling events linking TCR ligation to transcriptional activation and cytoskeletal rearrangement.
Mice.
To generate WASpΔGBD mice, a WASp cDNA deleted for sequences encoding amino acids 238–252 (WASpΔGBD) was introduced downstream of the CD2 promoter elements in the p29Δ2 vector and the transgene construct was then injected into CD1 embryos. Transgene+ founders were identified by Southern analysis and PCR using primer pairs: 5′-GGAGCACATCAG AAGGGCTGGCTT-3′ (forward) and 5′CGGAGGAACCAGAGGTGGACCT-3′ (reverse). Founders were then backcrossed to the C57BL/6 background and pups were screened for WASpΔGBD expression by immunoblotting analysis of lymphoid cell lysates using anti-WASp antibody. Selected WASpΔGBD transgenic lines were then mated with WASp-deficient (WAS−/−) mice (18) to derive animals expressing WASpΔGBD on the WAS−/− background (WAS−/−ΔGBD). Mice expressing the OVA-specific OT-II TCR transgene on the C57BL/6 background (provided by F. Carbone, University of Melbourne, Melbourne, Australia, and T. Watts, University of Toronto, Toronto, Canada; reference 19) were bred with WAS−/−, WAS−/−ΔGBD, and Fyn−/− (Jackson ImmunoResearch Laboratories) mice to generate WAS−/−/OT-II, WAS−/−ΔGBD/OT-II, and Fyn−/−/OT-II animals. C57BL/6 Itk−/− mice were provided by D. Fowell (University of Rochester Medical Center, Rochester, NY).
Reagents.
Reagents used for these studies included: polyclonal antibodies specific for WASp (raised against a synthetic peptide representing WASp residues 224–238), PSTPIP1 (5), and PTP-PEST (provided by M. Tremblay, McGill University, Montreal, Canada, and A. Veillette, Clinical Research Institute of Montreal, Montreal, Canada); monoclonal antibodies recognizing human and murine CD3 (from the OKT3 and 2C11 hybridomas, respectively), human and murine CD28 (from the 9.2 and 37.51 hybridomas, respectively), and human protein kinase C (PKC)-θ (Transduction Labs); monoclonal antiphosphotyrosine (pTyr) pTyr4G10 antibody (Upstate Biotechnology); goat anti–hamster IgG (BD Biosciences); Cy5-conjugated goat anti–rabbit Ig, Cy5–sheep anti–mouse Ig, and goat anti–hamster IgG (Jackson ImmunoResearch Laboratories); anti-Fyn antibodies and purified rabbit Ig (Santa Cruz Biotechnology, Inc.); rhodamine, FITC, and Alexa 350–phalloidin (Molecular Probes); and anti–green fluorescent protein (GFP) antibody (AbCam). Expression constructs for immunofluorescence studies were derived by subcloning cDNAs encoding full-length WASp, PSTPIP1, and PTP-PEST (provided by M. Tremblay) into the pEGFP-C3, pDSRED, and pcDNA3 expression vectors (CLONTECH Laboratories, Inc.). WASp tyrosine point mutation (tyrosine→phenylalanine) GFP-tagged expression constructs were generated by PCR-mediated mutagenesis of each WASp tyrosine residue and subcloning of the mutant cDNAs into the pEGFP-C3 vector. Expression constructs (pcDNA3) for cdc42, cdc42-V12, and cdc42-N17 were obtained from G. Downey (University of Toronto, Toronto, Canada) and expression constructs for Fyn K296M were obtained by PCR-mediated mutagenesis of the Fyn cDNA and subcloning into pcDNA3 vector.
T Cell Stimulation.
For T cell activation, 2 × 107 Jurkat E6, JCam-1, or JCam-1-Lck cells (20) cultured in RPM1 1640 plus 10% fetal bovine serum and 2 mM l-glutamine penicillin/streptomycin (GIBCO BRL) were serum starved overnight and then stimulated for varying times with 10 μg/ml anti-CD3 and 5 μg/ml anti-CD28 antibodies. Alternatively, 2 × 107 murine thymocytes or lymph node T cells were incubated with 5 μg/ml anti-CD3 and 2 μg/ml anti-CD28 antibodies on ice for 30 min followed by cross-linking with 5 μg anti–hamster IgG for varying times at 37°C. Aliquots of cell cultures were subjected to anti-pTyr immunoblotting analysis to confirm cell activation.
Immunoprecipitation and Immunoblotting.
To prepare cell lysates, 2 × 107 Jurkat cells, thymocytes, or lymph node T cells were suspended in lysis buffer (20 mM Tris-HCl, pH 7.5, 1% Triton X-100, 150 mM NaCl, 1 mM PMSF, 1 mM Na3VO4) and 1 μg/ml each aprotinin, leupeptin, and pepstatin (Amersham Biosciences). After 30 min of incubation on ice, unlysed cells were removed by centrifugation and 100–250 μg of the lysate proteins were then incubated with Protein A sepharose 6B beads (Amersham Biosciences) for 30 min at 4°C followed by 2 h of incubation with specific antibody or rabbit preimmune serum. The immune complexes were then collected over Protein A sepharose and eluted from the beads by boiling in Laemmli buffer. For immunoblotting analyses, immunoprecipitated proteins were suspended in loading buffer, electrophoresed through 10% polyacrylamide gels, and transferred to nitrocellulose membrane. After blocking with 5% skim milk powder in 1× TBST (20 mM Tris-HCl, pH 7.5, 0.9% NaCl, 0.1% Tween 20), membranes were incubated for 1 h with the primary antibody followed by a 1-h incubation with a 1/3,000 diluted horseradish peroxidase–conjugated secondary antibody (Bio-Rad Laboratories) and for 1 min with ECL substrate (Amersham Biosciences) followed by 1–10 min of exposure to Eastman Kodak Co. X-ray film.
Cell Proliferation Assay.
Single cell suspensions prepared from wild-type WAS−/− or WAS−/−ΔGBD thymi and lymph nodes were subjected to erythrocyte lysis in ammonium chloride buffer and then cultured in 96-well plates (2 × 106 cells/ml) for 48 h in culture medium alone or with 0–25 μg/ml plate-bound anti-CD3epsilon antibody with or without 0.2 μg/ml anti-CD28 antibody. Cultured cells were pulsed with 1 μCi/well [3H]thymidine for 18 h and incorporated radioactivity was measured using an automated β scintillation counter.
Generation of Fusion Proteins and In Vitro Binding Assays.
Fusion proteins were derived by transforming Escherichia coli with pGEX2T vectors containing full-length PSTPIP1, PTP-PEST, WASp, or cdc42 cDNAs, or PCR-amplified fragments representing the PSTPIP1 coiled coil (amino acids 120–358; PSTPIPCOIL) or SH3 (amino acids 365–415; PSTPIPSH3) domains, or pQE-30 vectors (QIAGEN) containing the Fyn, PST-PEST, or PSTPIP1 cDNAs. Fusion proteins were purified from isopropyl-1-thio-β-D-galactopyranoside–induced bacteria using glutathione-coupled sepharose 4B or Ni-NTA agarose beads (QIAGEN), and the amount of bound protein was estimated by Coomassie staining. For binding studies, 5 μg immobilized gluthathione S-transferase (GST) fusion proteins were incubated for 2 h at 4°C with either 250 μM purified 6XHis-tagged protein or lysates from stimulated Jurkat E6 cells. The immune complexes were resolved by SDS-PAGE and immunoblotting analysis was performed with the indicated antibodies. To assay WASp-cdc42 binding, 100 μg GST-cdc42 or GST alone immobilized on glutathione sepharose 4B beads was incubated for 10 min at 30°C with 50 μl GTPγS loading buffer (50 mM Tris-HCl, pH 7.5, 5 mM EDTA, 10 mM GTPγS) followed by the addition of 10 mM MgCl2. Beads were then incubated in 5 mM MgCl2 for 2 h at 4°C with 0.5 mg lysates obtained from Cos-7 cells 36 h after Lipofectamine-mediated transfection of pcDNA3.1 vectors encoding either WASp or WASpΔGBD. Complexes were washed and resolved by SDS-PAGE and sequential immunoblotting analysis was performed with anti-WASp and anti-cdc42 antibodies.
In Vitro Kinase Assay.
Fyn immunoprecipitates obtained from TCR-stimulated Jurkat cells were washed in kinase buffer (20 mM Hepes, pH 7.6, 150 mM NaCl, 5 mM MgCl2, 5 mM MnCl2, 0.25 mM Na3VO4, 0.5% Nonidet P-40, 0.1 mM 2-β-mercaptoethanol) and the complexes were incubated for 30 min at 30°C in kinase buffer containing 10 μCi [γ-32P]ATP (NEN Life Science Products) with 5 μg GST, GST-WASp, GST-WASpY291F, or GST-WASpΔPro fusion proteins. Samples were resuspended in Laemmli buffer and resolved in 10% SDS-PAGE gels. After electrotransfer to nitrocellulose, phosphorylated WASp was visualized by autoradiography.
NFAT Luciferase Reporter Assay.
Murine WAS−/− thymocytes (2 × 107 cells) were isolated and transfected with 50 μg of an NFAT luciferase reporter gene plus 50 μg pEGFP-C3 vectors encoding WASp-GFP, WASp Y→F GFP mutants, or GFP alone. After 4 h, viable cells were separated using Lympholyte M (Cedarlane) and the GFP+ cells were purified over a MoFlo® cell sorter (DakoCytomation) and cultured for 8 h in uncoated 96-well plates or in plates coated with 10 μg/ml anti-CD3 or 5 μg/ml anti-CD3 plus anti-CD28 antibody. Cells were lysed and luciferase activity was assayed using the luciferase assay system (Promega) and a luminometer.
Synapse Assay.
LB27.4 B cells (H-2d/b–restricted B cell hybrid; American Type Culture Collection) were incubated with OVA peptide (OVA329–339) for 4 h at 37°C followed by centrifugation at 200 g for 5 min with an equal number of lymph node T cells from transgenic mice or from WAS−/−/OT-II lymphocytes transfected with pEGFP-C3 or pDSRED expression constructs. Samples were incubated at room temperature for 10 min and the cells were resuspended and plated onto poly-l-lysine–coated coverslips (Biocoat; Becton Dickinson) before fixation in 3% paraformaldehyde. Synapse formation was scored as the percent conjugates (T cell in physical contact with an APC) showing actin accumulation at the T cell–APC interface.
Transfection and Immunofluorescence Assays.
Plasmid DNA for expression constructs containing PSTPIP1, PTP-PEST, WASp, WASpY291F, and WASpY102F cDNAs were purified using CLONTECH Laboratories, Inc. Maxi-Prep kit. 5 × 104 Cos-7 cells maintained in DMEM supplemented with 10% fetal bovine serum, l-glutamine, and penicillin/streptomycin, were seeded onto glass coverslips and transfected with selected plasmid DNA using Lipofectamine 2000 (Invitrogen). At 24 h after transfection, cells were washed and fixed with 3% ice-cold paraformaldehyde in PBS. Alternatively, unstimulated or stimulated OT-II T cells were transfected by electroporation (1 pulse, 360 mV) using a BTX electroporator and subjected to fixation at 2.5 h after transfection. After fixation, cells were blocked with 2% BSA/PBS for 10 min immediately or for intracellular staining, cells were first permeabilized with 0.1% Triton X-100/PBS. Cells were then incubated with primary and the appropriate fluorescently conjugated secondary antibodies and the stained samples were mounted in anti-fade mounting media (DakoCytomation). Images were analyzed using the Olympus 1X-70 inverted microscope equipped with fluorescence optics and Deltavision Deconvolution Software (Applied Precision).
In Vitro Actin Polymerization Assay.
Actin polymerization was evaluated by assaying increase in fluorescence of pyrene-labeled actin using the actin polymerization kit from Cytoskeleton, Inc. For these assays, cdc42-V12, PTP-PEST, and PSTPIP1 were purified as GST fusion proteins and these proteins or Fyn (Upstate Biotechnology) were added alone or in combination with 1.5× actin polymerization kit buffer containing 20 nM Arp2/3 complex, 100 nM GST-WASp or WASpΔGBD fusion protein, and 100 μl monomer pyrene actin stock in G buffer (5mM Tris-HCl, pH 8.0, 0.2 mM CaCl2, 0.5 mM DTT, and 0.2 mM ATP), with the final concentration of G actin being 2.8 μM. Fluorescence changes were monitored every minute for over 1 h at room temperature using a fluorometer (Photon Technology International) with filters for excitation at 365 nm and emission at 407 nm.
In Vivo Actin Polymerization Assays.
1.5 × 106 thymocytes obtained from WAS−/ΔGBD mice or by transfection of WAS−/ thymic cells with the pEGFP-C3 WASp Y→F mutant constructs were either unstimulated or stimulated with anti-CD3 and anti-CD28 antibodies for 30 min on ice followed by cross-linking with 5 μg mouse anti–hamster IgG for 5 min at 37°C. Activation was terminated and the cells were fixed in 5% paraformaldehyde, permeabilized with 0.1% Triton X-100 for 5 min on ice, washed and stained with 5 μg/ml FITC-conjugated phalloidin, and analyzed using a FACSCalibur™.
TCR-induced Proliferation and Actin Polymerization Proceed Normally in WAS−/−ΔGBD Mice.
Although activated cdc42 can bind WASp and trigger WASp VCA domain–mediated Arp2/3 activity (2, 3), it is unclear whether this interaction is required and/or solely responsible for induction of WASp effector function after TCR stimulation. To address this issue, the relevance of the GBD–cdc42 interaction to WASp effects on T cell activation was studied using mice in which a CD2 promoter/enhancer-driven WASp cDNA lacking the GBD (WASpΔGBD; Fig. 1 A) was expressed on the C57BL/6 WAS−/− background. After confirmation that the WASpΔGBD species does not bind activated cdc42 (Fig. 1 B) and demonstration that the WASpΔGBD transgene is expressed in T lineage cells (Fig. 1 C), WAS−/−ΔGBD mice were characterized with respect to T cell phenotype and function. In contrast to WAS−/− mice, in which thymocyte and peripheral T cell numbers are markedly reduced and thymocyte maturation impaired (18), the WAS−/−ΔGBD mice showed no defects in either T cell numbers or development (not depicted). Analysis of TCR-induced proliferation also revealed proliferative responses to anti-CD3 antibody or anti-CD3 and anti-CD28 antibodies to be essentially comparable in WAS−/−ΔGBD and control thymocytes and peripheral T cells, and markedly reduced in WAS−/− cells (Fig. 1 D). Similarly, immunofluorescence analysis of FITC phalloidin–stained WAS−/−ΔGBD thymocytes revealed CD3/CD28-induced actin polymerization, which is abrogated in WAS−/− cells, to be essentially normal in WAS−/−ΔGBD cells (Fig. 1 E). Together, these observations indicate the coupling of TCR engagement to proliferation and actin polymerization to be unaffected by absence of the WASp GBD and thus imply that WASp effects on TCR-induced transcriptional activation and cytoskeletal arrangement can be evoked by mechanisms other than cdc42–GBD interaction.
Figure 1.
Figure 1.
The GBD of WASp is not essential for WASp activity. (A) Scheme that shows the domain organization of wild-type and a GBD-deleted (WASpΔGBD) WASp cDNA used to derive WAS−/−ΔGBD mice. Positions of all tyrosine residues within (more ...)
Phosphorylation of WASp Tyrosine 291 Is Induced by TCR Engagement and Required for Induction of NFAT Translocation, Actin Polymerization, and Synapse Formation.
The negligible overt T cell functional deficit observed in WAS−/− ΔGBD mice implies that WASp activation in T cells might be mediated through non-GBD–dependent mechanisms. Data showing WASp or its orthologue, N-WASp, to undergo inducible tyrosine phosphorylation in B cells, platelets, and neurons (14, 21, 22) raise the possibility that TCR-evoked WASp tyrosine phosphorylation is relevant to the regulation of WASp function in T cells. To determine whether WASp is inducibly tyrosine phosphorylated after T cell stimulation, WASp immunoprecipitates from resting and TCR-stimulated Jurkat cells were subjected to anti-pTyr immunoblotting analysis. This analysis revealed WASp to be tyrosine phosphorylated constitutively in these cells, but to undergo a marked increase in tyrosine phosphorylation after TCR engagement (Fig. 2 A). Moreover, both basal and TCR-evoked WASp tyrosine phosphorylation levels appeared equivalent in thymocytes from wild-type and WAS−/−ΔGBD mice, suggesting that in T cells, WASp can be inducibly tyrosine phosphorylated in the absence of its interaction with activated cdc42 (Fig. 2 B). To determine which of the seven tyrosine resides within WASp (Fig. 1 A) undergo TCR-induced phosphorylation in vivo, cDNAs in which each tyrosine residue was individually replaced with phenylalanine (Y→F) were expressed as GFP-tagged proteins in Jurkat cells and phosphorylation status of the mutant proteins was examined after cell stimulation. As revealed by anti-pTyr immunoblotting analysis of anti-GFP immunoprecipitates from the transfected cells, induction of WASp tyrosine phosphorylation was unaffected by mutation at six of the seven WASp tyrosine sites, but was abrogated in cells expressing WASpY291F (Fig. 2 C). These findings indicate that TCR engagement triggers the tyrosine phosphorylation of WASp and demonstrate that Y291, a residue known to be selectively targeted by Btk (14), represents the major and likely only tyrosine site on WASp targeted for phosphorylation after TCR stimulation.
Figure 2.
Figure 2.
Figure 2.
TCR-induced phosphorylation of WASp Y291 is required for induction of NFAT activity, actin polymerization, and immunological synapse formation. (A) Lysates prepared from resting or TCR-stimulated Jurkat T cells at the indicated times after stimulation (more ...)
To examine the biologic relevance of WASp tyrosine phosphorylation in T cells and specifically determine whether Y291 phosphorylation modulates WASp function, WAS−/− T cells were reconstituted with the WASp Y→F mutants and the cells were then assayed for NFAT transcriptional activity and actin polymerization. As revealed using an NFAT luciferase reporter, induction of NFAT activity after CD3 or CD3/CD28 stimulation was profoundly reduced in WASp Y291F relative to wild-type WASp-expressing cells, but unaffected in the context of other WASp tyrosine mutations (Fig. 2 D). Similarly, immunofluorescence analysis of phalloidin-labeled WAS−/− thymocytes expressing either wild-type or tyrosine-substituted WASp mutants, revealed induction of actin polymerization to be disrupted by either WASp deficiency or WASpY291F expression (Fig. 2 E), but to proceed normally in cells expressing wild-type WASp, WASpY88F, WASpY212F (Fig. 2 E), or any of the other WASp mutants (not depicted). Therefore, Y291 phosphorylation modulates and is, in fact, required for WASp contribution to the induction of transcriptional activation and actin polymerization after TCR engagement.
The critical role for WASp Y291 phosphorylation in linking TCR engagement to actin polymerization implies that WASp effects on actin-mediated processes associated with T cell activation are also dependent on its phosphorylation at this site. To address this possibility, the effects of Y291F mutation on WASp capacity to promote immunological synapse formation after TCR stimulation were investigated using T cells from WAS−/− mice expressing a TCR transgene (OT-II) that specifically recognizes an epitope of OVA. For those studies, WAS−/−/OT-II T cells transfected with wild-type or the tyrosine-mutated WASp cDNAs were stimulated with OVA-pulsed APCs and synapse formation was then evaluated using immunofluorescence microscopy to monitor accumulation of polymerized actin and PKC-θ at the T cell–APC interface of developing conjugates. As is consistent with the essential role identified for WASp in synapse development (5), actin and PKC-θ accumulation indicative of synapse formation at the T cell–APC contact site was absent in WAS−/−/OT-II cells, but was fully restored by expression of wild-type WASp (Fig. 2 F, a and b). Induction of synapse formation in these cells was also restored by expression of WASp Y102F (Fig. 2 F, c) and all other WASp tyrosine mutants (not depicted) with the exception of WASpY291F, the latter of which translocated to the synaptic region after cell stimulation, but failed to evoke the actin reorganization and PKC-θ localization within this region that demarcate synapse formation (Fig. 2 F, d). These data suggest that WASp translocation to the T cell–APC contact zone occurs independently of its tyrosine phosphorylation, whereas formation of the immunological synapse after TCR engagement requires not only WASp, but also phosphorylation of WASp at Y291. Together, these findings reveal phosphorylation at the Y291 site to be critical for activation of WASp effector function in T cells and thus imply that this modification enables the release of WASp from autoinhibitory structural constraints.
Tyrosine Phosphorylation of WASp Is Regulated by Fyn and PTP-PEST.
Phosphorylation of WASp at Y291 by both Btk and Hck has been demonstrated in exogenous expression systems (14, 15), but the PTKs modulating Y291 phosphorylation in vivo in T cells have not been defined. Similarly, although WASp has been shown to bind GST fusion proteins containing the Itk, Lck, or Fyn SH3 domains and associate with Fyn in transformed monocytes (1618), the relevance of these interactions to the in vivo induction of WASp tyrosine phosphorylation in T cells remains unknown. To address these issues, induction of WASp tyrosine phosphorylation was evaluated in T cells deficient for Itk, Lck, or Fyn. As shown in Fig. 3 A, immunoblotting analysis revealed no differences in the levels of WASp tyrosine phosphorylation elicited in T cells from Itk-deficient compared with wild-type mice. Similarly, comparisons between Lck-deficient JCam-1 cells and JCam-1 cells reconstituted for Lck expression revealed induction of WASp tyrosine phosphorylation to be unaffected by Lck deficiency. By contrast, T cells from Fyn-deficient mice showed no detectable increase in tyrosine phosphorylation in response to TCR engagement. Moreover, TCR-elicited WASp tyrosine phosphorylation was markedly lower in Jurkat cells coexpressing wild-type and a catalytically inert Fyn (FynK296M) protein (23) compared with cells expressing only wild-type Fyn and was essentially abrogated by the sole overexpression of FynK296M (Fig. 3 B). These data indicate that Fyn, but not Itk or Lck, is required for WASp tyrosine phosphorylation and raise the possibility that WASp might be exclusively tyrosine phosphorylated by Fyn in T cells. Importantly, the coexpression in Jurkat cells of Fyn with either dominant negative (cdc42-N17) or activated (cdc42-V12) cdc42 mutant proteins had no effect on TCR-induced WASp tyrosine phosphorylation, implying that Fyn phosphorylates WASp independently of cdc42 activity (Fig. 3 C).
Figure 3.
Figure 3.
Fyn binds and phosphorylates WASp after TCR engagement. (A) Lymphocytes from Itk−/−, Fyn−/−, and wild-type mice as well as JCam-1 (Lck-deficient) and Lck-reconstituted JCam-1 (JCam + Lck) cells were stimulated with anti-CD3/anti-CD28 (more ...)
Because these findings suggest that WASp is a Fyn substrate, Fyn association with WASp was evaluated in Jurkat cells. As shown in Fig. 3 D, these proteins inducibly interact with one another after CD3/CD28 stimulation. The capacity of Fyn to bind directly to WASp was also examined by incubating polyhistidine-tagged Fyn (His Fyn) with glutathione sepharose–bound GST fusion proteins containing wild-type WASp or a WASp mutant lacking the proline-rich region (WASpΔPro). Anti-Fyn immunoblotting analysis of these complexes revealed interaction of His Fyn proteins with the GST-WASp fusion protein, but not with control GST or GST-WASpΔPro proteins (Fig. 3 E). Thus, the association of Fyn with WASp is direct and requires the WASp proline-rich region and its likely binding to the Fyn SH3 domain.
To determine whether Fyn directly phosphorylates WASp, the effects of Fyn on the WASp phosphorylation state were assessed using an in vitro kinase assay. As shown in Fig. 3 F, Fyn immunoprecipitates from activated T cells induced the tyrosine phosphorylation of WASp, but neither WASpΔPro nor WASpY291F mutant proteins were phosphorylated in this assay. These findings suggest that Fyn-mediated WASp phosphorylation requires the physical association of these proteins and that it is Y291 and no other WASp tyrosine residue that is targeted by Fyn during T cell activation.
The relationship between tyrosine phosphorylation and WASp effector activity in T cells implies that PTP-mediated dephosphorylation of WASp is also important to WASp functions in T cell activation. Previous studies of WASp ligands in T cells have revealed that WASp inducibly associates with a cytosolic adaptor, PSTPIP1, also known to bind a hemopoietic PTP, PTP-PEST (5, 24). These observations raise the possibility that WASp might be juxtaposed to and thereby dephosphorylated by PST-PEST via its association with PSTPIP1, a paradigm observed in relation to PTP-PEST–mediated dephosphorylation of the c-Ab1 PTK (25). To determine whether these effectors associate with one another in T cells, PSTPIP1 immunoprecipitates from CD3/CD28-stimulated T cells were examined for the presence of WASp and PTP-PEST. As shown in Fig. 4 A, both WASp and PTP-PEST coimmunoprecipitated with PSTPIP1. PTP-PEST was also detected in WASp immunoprecipitates from stimulated T cells (Fig. 4 B), but recombinant WASp and PST-PEST did not associate in an in vitro binding assay, suggesting that their interaction is indirect and possibly mediated via PSTPIP1. To address this possibility and extend data on the structural basis for PSTPIP–PTP-PEST interaction (26), GST fusion proteins containing full-length PSTPIP1 or either of its major protein-binding domains (a coiled coil and an SH3 domain) were assessed for capacity to precipitate PTP-PEST from stimulated T cells. Results of this analysis revealed the interaction of PTP-PEST with GST fusion proteins containing full-length PSTPIP1 or the PSTPIP1 coiled coil region alone, but not with GST-PSTPIP1 SH3 domain fusion protein (Fig. 4 C). As PSTPIP has previously been shown to bind via its SH3 domain to WASp (5), these findings suggest that WASp and PST-PEST interact via their mutual binding to PSTPIP. Because these three proteins have each been implicated in actin cytoskeletal rearrangement (1, 23, 27), the functional relevance of a trimolecular WASp–PSTPIP1–PTP-PEST interaction was investigated using fluorescence microscopy to evaluate the localization of these proteins with respect to one another and to actin. As shown in Fig. 4 D, rhodamine phalloidin staining of Cos-7 cells expressing GFP-tagged WASp, PSTPIP1, or PTP-PEST revealed each of these proteins to be highly or entirely colocalized with actin structures, WASp being concentrated in actin-rich perinuclear aggregates, and PSTPIP1 and PTP-PEST localizing to actin fibrillary networks spanning the cytoplasm. Coexpression of PSTPIP1 and PTP-PEST revealed these protein to be colocalized and distributed similarly as when expressed alone (Fig. 4 D, d). When coexpressed with PSTPIP1 and PTP-PEST, WASp also showed a distribution pattern overlapping that of PSTPIP1/PTP-PEST (Fig. 4 D, e). Thus, as shown for PSTPIP1 (5), PSTPIP1/PTP-PEST association with WASp appears to evoke WASp relocalization such that these three effectors colocalize within the actin cytoskeleton, as is suggestive of a biological role for PSTPIP1-mediated linkage of WASp to PTP-PEST.
Figure 4.
Figure 4.
WASp inducibly associates and colocalizes with PSTPIP1 and PTP-PEST. (A) Jurkat T cells were stimulated for the indicated times with anti-CD3 and anti-CD28 antibodies and lysates were then prepared and immunoprecipitated with anti-PSTPIP1 antibody. The (more ...)
In view of its capacity to associate and colocalize with PTP-PEST, the potential for WASp to serve as a PTP-PEST substrate in T cells was examined by coexpressing WASp with PTP-PEST or a catalytically inactive form of PTP-PEST (PTP-PEST C231S) in Jurkat cells and examining these cells with respect to inducible WASp tyrosine phosphorylation status. As shown in Fig. 4 E, TCR-induced WASp tyrosine phosphorylation in these cells is essentially abrogated by PTP-PEST overexpression, but is enhanced by expression of catalytically inactive and likely dominant negative–acting PTP-PEST C231S. Thus, PTP-PEST–mediated tyrosine dephosphorylation may counteract Fyn-mediated phosphorylation of WASp after T cell stimulation and, by extension, WASp contributions to T cell activation might be modulated by the relative balance of these respective enzyme activities.
Fyn and PTP-PEST Modulate WASp Effects on Induction of Actin Polymerization and Immunological Synapse Formation.
In view of the effects of Fyn and PTP-PEST on WASp tyrosine phosphorylation and relevance of Y291 phosphorylation to WASp function, the possibility that Fyn and/or PTP-PEST modulate the ability of WASp to activate the Arp2/3 complex was directly tested using a pyrene fluorescence in vitro assay of actin polymerization. As shown in Fig. 5 A, WASp alone stimulated some polymerization of the pyrene-labeled actin, but the effect of WASp on actin polymerization was dramatically increased by the addition of Fyn. Because WASp effector activity can also be stimulated by cdc42 (1, 3), the efficacies of Fyn and cdc42 in triggering either WASp or WASpΔGBD-mediated actin polymerization were also compared using a GST fusion protein containing constitutively active cdc42 (cdc42-V12). Although GST–cdc42-V12 substantively enhanced WASp-mediated actin polymerization, when added at a concentration generating maximum Arp2/3 activation, its effects on actin polymerization were no greater than those induced by Fyn and were not increased by the addition of GST-Fyn (Fig. 5 A). Similarly, the addition of either GST-Fyn or GST–cdc42-V12 alone or in combination at concentrations yielding lower levels of WASp-Arp2/3 activation revealed the effects of cdc42-V12 and Fyn together to be less than additive (Fig. 5 B). Thus, although Fyn and cdc42 both stimulate WASp-mediated actin polymerization, they do not act synergistically to activate WASp. By contrast, the addition of PTP-PEST and PSTPIP1 had a dramatic effect on Fyn's capacity to stimulate WASp activity with the level of WASp-Arp2/3 activity evoked by the combination of Fyn with PTP-PEST and PSTPIP1 being comparable to that triggered by WASp alone and being even further diminished by the combination of PTP-PEST and PSTPIP1 (Fig. 5 A). Thus, as is consistent with a key role for tyrosine phosphorylation in regulating WASp function, these data reveal WASp's effects on actin polymerization to be modulated by both Fyn and PTP-PEST/PSTPIP1. The data also reveal Fyn to be as efficacious as cdc42 in stimulating WASp-Arp2/3 activity and modulating this activity independently of the WASp GBD.
Figure 5.
Figure 5.
Fyn and PTP-PEST modulate WASp effects on induction of actin polymerization and synapse formation. (A) Polymerization of 2.8 μM pyrene-labeled actin monomer was assayed in the presence of 20 nM Arp2/3 complex, 100 nM GST-WASp or GST-WASpΔGBD, (more ...)
To directly establish the relevance of Fyn and PTP-PEST to WASp functions in T cells, the capacity of these effectors to modulate WASp effects on immunological synapse formation was also investigated using the OT-II transgenic mice as well as mice expressing the OT-II transgene on the Fyn−/− background. As shown in Fig. 5 C, stimulation of T cells from OT-II TCR mice with OVA peptide–pulsed APCs induced translocation of both WASp and Fyn to the T cell–APC interface where they colocalized with a region of intense actin accumulation demarcating the developing synapse. Three-dimensional reconstruction and 90°C rotation of the interface area confirmed published data indicating Fyn to be concentrated centrally within the synapse (28) and revealed WASp to be distributed between both the central and peripheral synaptic region. By contrast, synapse formation, as revealed by actin accumulation at the T cell–APC interface, was essentially not detectable in conjugates formed between Fyn−/−/OT-II cells and antigen-pulsed APCs (Fig. 5 C, c and e). Synapse formation was also found to be impaired by the coexpression of PTP-PEST with WASp in WAS−/−/OT-II cells with percentages of synapses formed being at least 50% lower than observed between APCs and WASp-expressing cells (Fig. 5 D, d). As is consistent with the role of PSTPIP1 in coupling PTP-PEST to WASp, the coincident expression of WASp, PSTPIP1, and PTP-PEST in these cells had an even more deleterious effect on synapse formation and, as with Fyn deficiency, abrogated actin accumulation at the T cell–APC interface (Fig. 5 D, c and d). These results are in agreement with published data indicating that Fyn and PSTPIP1 translocate to the T cell–APC contact region after TCR stimulation (5, 28) and suggest that Fyn and PSTPIP/PTP-PEST colocalization with WASp within this region influences WASp capacity to evoke the actin polymerization and cytoskeletal change required for synapse formation. Thus, these data provide further evidence that Fyn and PTP-PEST effects on the tyrosine phosphorylation of WASp are critical to the induction of WASp effector activities required for T cell activation.
The data reported here identify phosphorylation at Y291 as a major mechanism for induction of WASp effector activity after TCR engagement. A requirement for WASp “activation” in T cells is consistent with cumulative data revealing WASp to be constitutively autoinhibited (13) and identifying induction of actin polymerization as a critical facet of the T cell response to antigen stimulation (29). The current data identifying Fyn as the PTK responsible for WASp phosphorylation in T cells and implicating PTP-PEST in WASp dephosphorylation in these cells are also in agreement with previous data indicating an essential role for Fyn in induction of cytoskeletal reorganization after TCR engagement (30) and demonstrating that PTP-PEST acts as a negative regulator of lymphocyte activation (31). Taken together with the observed capacity of Fyn to promote and PTP-PEST to inhibit WASp stimulatory effects on Arp2/3 polymerizing function, these findings suggest that tyrosine phosphorylation alone can mediate induction of WASp activity after TCR engagement. By contrast, based on the results of in vitro binding assays, it has recently been suggested that tyrosine phosphorylation effects on WASp activity require its binding to cdc42 (32). Although the current data do not preclude cdc42 binding as a mechanism for activating WASp, the normal behavior of the WASpΔGBD T cells studied here together with the catastrophic effects of Y291 mutation on WASp function and T cell activation indicate that the in vivo induction of WASp effector activity absolutely requires WASp tyrosine phosphorylation and can occur independently of cdc42 binding to WASp. These data do not exclude the possibility that the ΔGBD mutation alters WASp structure so as to disrupt normal autoinhibitory constraints on WASp activity. However, no evidence for “constitutive” T cell activation was observed in the WAS−/− ΔGBD T cells and the data suggest that WASpΔGBD is constitutively inactive and requires an activation signal for function. Further, although Lyn/Btk-mediated phosphorylation of WASp has been reported to require cdc42 (33), the current data revealing Fyn-mediated tyrosine phosphorylation to be unaffected by constitutively active or dominant negative forms of cdc42 and the GBD deletion to have no effect on Fyn-driven WASp-Arp2/3 actin polymerization in vitro, provide compelling evidence to support previous data indicating that cdc42 binding is not essential for triggering WASp activity (13, 15).
The association of Y291 phosphorylation with induction of WASp effector activity raises the possibility that WASp activation also involves its interactions with SH2 domain–containing signaling effectors. Such effectors may include WASp-binding adaptors, such as Nck and Grb2, and kinases, such as Fyn, whose interactions with WASp are mediated via SH3 domain binding to the WASp polyproline region, but may also involve SH2 domain binding to the WASp phosphorylated Y291 residue. Phosphorylation at the Y291 site may also enable currently undefined WASp interactions with SH2 domain–containing effectors and thereby broaden the repertoire of WASp binding so as to facilitate WASp activation as well as its participation in TCR-evoked signaling cascades. Similarly, although Fyn appears to represent the major mediator of WASp tyrosine phosphorylation in T cells, the current data do not exclude the possibility that WASp ligands include tyrosine phosphatases, which like PTP-PEST, target WASp for dephosphorylation and functional deactivation. Although these issues require further investigation, the data presented here indicate the modulation of WASp tyrosine phosphorylation by Fyn and PTP-PEST to be critical to the induction of WASp effector activity in T cells and thus identify WASp tyrosine phosphorylation as essential to its contributions to the coupling of TCR engagement to T cell activation.
Acknowledgments
The authors thank Drs. Deborah Fowell, Michel Tremblay, Andre Veillette, and Tania Watts for kind provision of reagents and Dr. G. Downey for a generous loan of equipment.
This work was supported by grants to K.A. Siminovitch from the Canadian Institutes for Health Research (CIHR) and the Arthritis Society of Canada. K. Badour is a recipient of an Ontario Student Trust Funds studentship award and K.A. Siminovitch is a CIHR Senior Scientist.
Notes
Abbreviations used in this paper: GBD, GTPase binding domain; GFP, green fluorescent protein; GST, gluthathione S-transferase; PKC, protein kinase C; PSTPIP, proline, serine, threonine phosphatase interacting protein; PTK, protein tyrosine kinase; PTP, protein tyrosine phosphatase; pTyr, phosphotyrosine; VCA, verprolin homology central region-acidic region; WASp, Wiskott-Aldrich syndrome protein.
1. Badour, K., J. Zhang, and K.A. Siminovitch. 2003. The Wiskott-Aldrich syndrome protein: forging a link between actin and cell activation. Immunol. Rev. 192:98–112. [PubMed]
2. Machesky, L.M., and R.H. Insall. 1998. Scar1 and the related Wiskott-Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex. Curr. Biol. 8:1347–1356. [PubMed]
3. Rohatgi, R., L. Ma, H. Miki, M. Lopez, T. Kirchhausen, T. Takenawa, and M.W. Kirschner. 1999. The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell. 97:221–231. [PubMed]
4. Cory, G.O., R. Cramer, L. Blanchoin, and A.J. Ridley. 2003. Phosphorylation of the WASp-VCA domain increases its affinity for the Arp2/3 complex and enhances actin polymerization by WASp. Mol. Cell. 11:1229–1239. [PubMed]
5. Badour, K., J. Zhang, F. Shi, M.K. McGavin, V. Ramperasad, L.A. Hardy, D. Field, and K.A. Siminovitch. 2003. The Wiskott-Aldrich syndrome protein acts downstream of CD2 and the CD2AP and PSTPIP1 adaptors to promote formation of the immunological synapse. Immunity. 18:141–154. [PubMed]
6. Sasahara, Y., R. Rachid, M.J. Byrne, M.A. de la Fuente, R.T. Abraham, N. Ramesh, and R.S. Geha. 2003. Mechanism of recruitment of WASp to the immunological synapse and of its activation following TCR ligation. Mol. Cell. 10:1269–1281.
7. McGavin, M.K., K. Badour, L.A. Hardy, T.J. Kubiseski, J. Zhang, and K.A. Siminovitch. 2001. The intersectin 2 adaptor links Wiskott Aldrich syndrome protein (WASp)-mediated actin polymerization to T cell antigen receptor endocytosis. J. Exp. Med. 194:1777–1787. [PMC free article] [PubMed]
8. Tian, L., D.L. Nelson, and D.M. Stewart. 2000. Cdc42-interacting protein 4 mediates binding of the Wiskott-Aldrich syndrome protein to microtubules. J. Biol. Chem. 275:7854–7861. [PubMed]
9. Anton, I.M., W. Lu, B.J. Mayer, N. Ramesh, and R.S. Geha. 1998. The Wiskott-Aldrich syndrome protein-interacting protein (WIP) binds to the adaptor protein Nck. J. Biol. Chem. 273:20992–20995. [PubMed]
10. Dupré, L., A. Aliuti, S. Tritari, S. Martino, P. Saracco, C. Bordignon, and M.G. Roncarolo. 2002. Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity. 17:157–166. [PubMed]
11. Prehoda, K.E., J.A. Scott, R.D. Mullins, and W.A. Lim. 2000. Integration of multiple signals through cooperative regulation of N-WASp-Arp2/3 complex. Science. 290:801–806. [PubMed]
12. Kim, A.S., L.T. Kakalis, N. Abdul-Manan, G.A. Liu, and M.K. Rosen. 2000. Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature. 404:151–158. [PubMed]
13. Kato, M., H. Milki, K. Imai, S. Nonoyama, T. Suzuki, C. Sasakawa, and T. Takenawa. 1999. Wiskott-Aldrich syndrome protein induces actin clustering without direct binding to Cdc42. J. Biol. Chem. 274:27225–27230. [PubMed]
14. Baba, Y., S. Nonoyama, M. Matsushita, T. Yamadori, S. Hashimoto, K. Imai, S. Arai, T. Kunikata, M. Kurimoto, T. Kurosaki, et al. 1999. Involvement of Wiskott-Aldrich syndrome protein in B-cell cytoplasmic tyrosine kinase pathway. Blood. 93:2003–2012. [PubMed]
15. Cory, G.O., R. Garg, R. Cramer, and A.J. Ridley. 2003. Phosphorylation of tyrosine 291 enhances the ability of WASp to stimulate actin polymerization and filopodium formation. Wiskott-Aldrich syndrome protein. J. Biol. Chem. 277:45115–45121.
16. Banin, S., O. Truong, D.R. Katz, M.D. Waterfield, P.M. Brickell, and I. Gout. 1996. Wiskott-Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases. Curr. Biol. 6:981–988. [PubMed]
17. Bunnell, S.C., P.A. Henry, R. Kolluri, T. Kirchhausen, R.J. Rickles, and L.J. Berg. 1996. Identification of ITK/Tec Src homology 3 domain ligands. J. Biol. Chem. 271:25646–25656. [PubMed]
18. Zhang, J., A. Shehabeldin, L.A. da Cruz, J. Butler, A.K. Somani, M. McGavin, I. Kozieradzki, A.O. dos Santos, A. Nagy, S. Grinstein, et al. 1999. Antigen receptor–induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein–deficient lymphocytes. J. Exp. Med. 190:1329–1341. [PMC free article] [PubMed]
19. Barnden, M.J., J. Allison, W.R. Heath, and F.R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76:34–40. [PubMed]
20. Oyaizu, N., S. Than, T.W. McCloskey, and S. Pahwa. 1995. Requirement of p561ck in T-cell receptor/CD3-mediated apoptosis and Fas-ligand induction in Jurkat cells. Biochem. Biophys. Res. Commun. 213:994–1001. [PubMed]
21. Oda, A., H.D. Ochs, B.J. Druker, K. Ozaki, C. Watanabe, M. Handa, Y. Miyakawa, and Y. Ikeda. 1998. Collagen induces tyrosine phosphorylation of Wiskott-Aldrich syndrome protein in human platelets. Blood. 92:1852–1858. [PubMed]
22. Suetzugu, S., M. Hattori, H. Miki, T. Tezuka, T. Yamamoto, K. Mikoshiba, and T. Takenawa. 2002. Sustained activation of N-WASP through phosphorylation is essential for neurite extension. Dev. Cell. 3:645–658. [PubMed]
23. Takata, M., and T. Kurosaki. 1995. The catalytic activity of Src-family tyrosine kinase is required for B cell antigen receptor signaling. FEBS Lett. 374:407–411. [PubMed]
24. Spencer, S., D. Dowbenko, J. Cheng, W. Li, J. Brush, S. Utzig, V. Simanis, and L.A. Lasky. 1997. PSTPIP: a tyrosine phosphorylated cleavage furrow-associated protein that is a substrate for a PEST tyrosine phosphatase. J. Cell Biol. 138:845–860. [PMC free article] [PubMed]
25. Cong, F., S. Spencer, J.F. Cote, Y. Wu, M.L. Tremblay, L.A. Lasky, and S.P. Goff. 2000. Cytoskeletal protein PSTPIP1 directs the PEST-type protein tyrosine phosphatase to the c-Ab1 kinase to mediate Ab1 dephosphorylation. Mol. Cell. 6:1413–1423. [PubMed]
26. Coté, J.F., P.L. Chung, J.-F. Jheberge, M. Hall, S. Spencer, L.A. Lasky, and M.L. Tremblay. 2002. PSTPIP is a substrate of PTP-PEST and serves as a scaffold guiding PTP-PEST toward a specific dephosphorylation of WASp. J. Biol. Chem. 277:2973–2986. [PubMed]
27. Angers-Loustau, A., J.F. Cote, A. Charest, D. Dowbenko, S. Spencer, L.A. Lasky, and M.L. Tremblay. 1999. Protein tyrosine phosphatase-PEST regulates focal adhesion disassembly, migration, and cytokinesis in fibroblasts. J. Cell Biol. 144:1019–1031. [PMC free article] [PubMed]
28. Monks, C.R., B.A. Freiberg, H. Kupfer, N. Sciaky, and A. Kupfer. 1998. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature. 395:82–86. [PubMed]
29. Wülfing, C., and M.M. Davis. 1998. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science. 282:2266–2269. [PubMed]
30. Huang, J., D. Tilly, A. Altman, K. Sugie, and H.M. Grey. 2000. T-cell receptor antagonists induce Vav phosphorylation by selective activation of Fyn kinase. Proc. Natl. Acad. Sci. USA. 97:10923–10929. [PubMed]
31. Davidson, D., and A. Veillette. 2001. PTP-PEST, a scaffold protein tyrosine phosphatase, negatively regulates lymphocyte activation by targeting a unique set of substrates. EMBO J. 20:3414–3426. [PubMed]
32. Torres, E., and M.K. Rosen. 2003. Contingent phosphorylation/dephosphorylation provides a mechanism of molecular memory in WASp. Mol. Cell. 11:1215–1227. [PubMed]
33. Guinamard, R., P. Aspenström, M. Fougereau, P. Chavrier, and J. Guillemot. 1998. Tyrosine phosphorylation of the Wiskott-Aldrich syndrome protein by Lyn and Btk is regulated by Cdc42. FEBS Lett. 434:431–436. [PubMed]
Articles from The Journal of Experimental Medicine are provided here courtesy of
The Rockefeller University Press